Studies of the Angle Kappa and the Angle Alpha (EKAPS)

October 28, 2021 updated by: Assistance Publique - Hôpitaux de Paris

Studies of the Characteristics of the Angle Kappa and the Angle Alpha in the Healthy Individual. Studies of the Angle Kappa and the Angle Alpha

Anatomical ophthalmological connections and their dynamics are still debated in the scientific community. However, their considering is essential in many surgeries (strabismus, cataract, refractive...) or in clinical practice.

The correlation between these biometric values would make it possible to refine the knowledge related to these landmarks and thus offer better ophthalmological management by integrating these variables into the clinical examination.

The aim of the study is to analyze the correlation between the angle alpha and the angle kappa in a healthy individual without ophthalmologic disorder.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The angle kappa corresponds to the angle formed between the visual axis (line between the point of fixation and the fovea: area of the retina allowing precise vision) and the pupillary axis (line passing through the center of the pupil and perpendicular to the cornea). The angle alpha corresponds to the angle formed between the visual axis and the optical axis (line passing through the nodal point of the eye and corneal center).

In theory, the angle kappa and angle alpha are equal; but physiological corectopy in the nasal position induces a variation between these two angles; the angle kappa being generally less than the angle alpha without a correlation being established. Also, pupillary constriction causes a variation in the position of the center of the pupil. The angle kappa therefore exhibits a variation depending on the expansion.

Anatomical ophthalmological connections and their dynamics are still debated in the scientific community. However, their considering is essential in many surgeries (strabismus, cataract, refractive ...) or in clinical practice.

The correlation between these biometric values would make it possible to refine the knowledge related to these landmarks and thus offer better ophthalmological management by integrating these variables into the clinical examination.

The aim of the study is to analyze the correlation between the angle alpha and the angle kappa in a healthy individual without an eye disorder.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75015
        • Hôpital Necker-Enfants Malades

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy individuals without visual disorders

Description

Inclusion Criteria:

- Informed major subject not opposing to their participation in the study

Exclusion Criteria:

- Subject with strabismus or organic ophthalmologic pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy individual
  • Multimodal fundus imaging (color fundus photography, optical coherence tomography (OCT))
  • orthoptic assessment (Visual acuity, Refraction, Cover test, Stereopsis evaluation
  • ocular biometry
  • corneal topography
  • monocular photographs in photopic and scotopic condition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Value of the angle Kappa
Time Frame: Day 0
Semi-automatic digital method of measurement by eye photography
Day 0
Value of the angle Alpha
Time Frame: Day 0
Semi-automatic digital method of measurement by eye photography
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation of the Kappa angle depending on the pupillary diameter
Time Frame: Day 0
Variation in the same individual. Value of the Kappa angle using the semi-automatic method of measurement by ocular photography in photopic and scotopic conditions & measurement of the pupillary diameter using the photographs obtained
Day 0
Correlation between the value of the angle Alpha and the Optic disc / fovea distance
Time Frame: Day 0
Angle Alpha value using the semi-automatic method of measurement by eye photography and the distance between the optic disc and the fovea
Day 0
Correlation between the angle Kappa and the axial length
Time Frame: Day 0
Value of the angle Kappa and Alpha using the semi-automatic method of measurement by eye photography and Value of the axial length measured by biometry IolMaster 500 (Carl Zeiss)
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maxence Rateaux, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 19, 2021

Primary Completion (ACTUAL)

October 4, 2021

Study Completion (ACTUAL)

October 4, 2021

Study Registration Dates

First Submitted

May 10, 2021

First Submitted That Met QC Criteria

May 10, 2021

First Posted (ACTUAL)

May 14, 2021

Study Record Updates

Last Update Posted (ACTUAL)

October 29, 2021

Last Update Submitted That Met QC Criteria

October 28, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • APHP210289
  • 2020-A03370-39 (OTHER: IDRCB number)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on No Eye Disorder

Clinical Trials on Eye examination

3
Subscribe